title: Spontaneous chromosome loss and colcemid resistance in lymphocytes from patients with myotonic dystrophy type 1.
abstract: Myotonic Dystrophy type 1 (DM1) is one of the many inherited human diseases whose molecular defect is the expansion of a trinucleotide DNA sequence. DM1 shares with fragile X syndrome (FMR1), another "unstable triplet syndrome", several molecular features not present in the remaining triplet diseases. As FMR1 is also characterised by chromosome instability at the site of the expanded triplet, lymphocytes from DM1 patients and healthy donors were cultured for micronucleus (MN) analysis, in order to verify if DM1 is also prone to chromosome instability. A FISH analysis was also carried out to detect the presence of centromeric sequences in the observed MN. The data indicate that DM1 patients present a percentage of centromere-positive MN significantly higher than controls, suggesting that chromosome loss is the main mechanism underlying the origin of the increased spontaneous instability. To further assess the proneness to instability of cells of DM1 patients, cultures from patients and controls were treated in vitro with growing concentrations of two different mutagens: colcemid, a "pure" aneugen compound whose target is tubulin, and mytomicin C, a strong clastogen. The results show that the patient group is significantly less sensitive to colcemid. These data, together with FISH analysis, suggest the presence, in DM1 patients, of an already damaged tubulin, which becomes no more sensitive to the effect of colcemid and which could be the main defect underlying the aneugenic effects in DM1.
authors.affiliation: Institute of Clinical Physiology, CNR, Cellular Biology and Cytogenetics Unit, Pisa (Italy).
authors.forename: M
authors.initials: M
authors.lastname: Casella
authors.forename: M
authors.initials: M
authors.lastname: Lucarelli
authors.forename: M
authors.initials: M
authors.lastname: Simili
authors.forename: P
authors.initials: P
authors.lastname: Beffy
authors.forename: R
authors.initials: R
authors.lastname: Del Carratore
authors.forename: F
authors.initials: F
authors.lastname: Minichilli
authors.forename: C
authors.initials: C
authors.lastname: Chisari
authors.forename: S
authors.initials: S
authors.lastname: Simi
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D003703:Demecolcine / Q000494:pharmacology*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D048629:Micronuclei, Chromosome-Defective / Q000187:drug effects / Q000235:genetics; D008875:Middle Aged; D008940:Mitotic Index; D009223:Myotonic Dystrophy / Q000235:genetics* / Q000473:pathology; D012737:Sex Factors; D012854:Sister Chromatid Exchange / Q000187:drug effects
chemical_list: D003703:Demecolcine